A month after Verastem Inc. got orphan drug designation in Europe for its potential drug to treat a rare form of lung cancer, the Cambridge biotech received the same designation in the U.S. The designation for VS-6063 as a treatment for mesothelioma could mean a faster approval process for the drug and a longer period before competition from … (more)
